Drug Trial Radar · NCT02914561
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Last checked: Nov 19, 2026Latest source record: Dec 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,372
Actual
Start
Oct 31, 2016
Primary completion
Nov 11, 2022
Study completion Nov 11, 2022
Sponsor
- Lead sponsor
- Lakefront Biotherapeutics NVIndustry
- Sponsor type
- Industry
- Collaborators
- Gilead Sciences
- First posted
- Sep 26, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a separate long-term extension (LTE) study (Study GS-US-419-3896).
Conditions
- Crohn's Disease
Interventions
FilgotinibDrug
Filgotinib tablets administered orally once daily.
PlaceboOther
Placebo administered orally once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Induction Study: Percentage of Participants Who Achieved Clinical Remission by Crohn's Disease Activity Index (CDAI) at Week 10Time frame: Week 10
- Induction Study: Percentage of Participants Who Achieved Endoscopic Response at Week 10Time frame: Week 10
- Maintenance Study: Percentage of Participants Who Achieved Clinical Remission by CDAI at Week 58Time frame: Week 58
- Maintenance Study: Percentage of Participants Who Achieved Endoscopic Response at Week 58Time frame: Week 58
Locations
513 sites in 41 countries. Site status is shown where the registry gives one.
Digestive Health Specialists of the Southeast
Dothan, Alabama
Arizona Digestive Health - Sun City
Sun City, Arizona
Southern California Research Center, Inc.
Coronado, California
VVCRD Research
Garden Grove, California
UC San Diego Health System
La Jolla, California
Cedars Sinai Medical Center
Los Angeles, California
Inland Empire Clinical Trials, LLC
Rialto, California
Kaiser Permanente
San Francisco, California
Clearview Medical Research, LLC
Santa Clarita, California
University of Colorado Denver and Hospital
Aurora, Colorado
South Denver Gastroenterology, PC
Lone Tree, Colorado
Connecticut GI, PC-Research Division
Farmington, Connecticut
Medstar Georgetown University Hospital (Patient Exams)
Washington D.C., District of Columbia
Advanced Research, LLC
Coral Springs, Florida
UF Clinical Research Center
Gainesville, Florida
Florida Research Institute
Lakewood Rch, Florida
Florida Center for Gastroenterology
Largo, Florida
University of Miami Crohn's and Colitis Center
Miami, Florida
Advanced Pharma CR
Miami, Florida
Cordova Research Institute
Miami, Florida
Vista Health Research, LLC
Miami, Florida
Gastroenterology Group of Naples
Naples, Florida
Center for Interventional Endoscopy - AdventHealth Orlando
Orlando, Florida
Gulf Region Clinical Research Institute
Pensacola, Florida
Advanced Medical Research Center
Port Orange, Florida
Tampa General Hospital
Tampa, Florida
Shafran Gastroenterology Center
Winter Park, Florida
Florida Medical Clinic, P.A.
Zephyrhills, Florida
Gastroenterology Associates of Central Georgia, LLC
Macon, Georgia
Gastrointestinal Specialists of Georgia
Marietta, Georgia
Atlanta Gastroenterology Specialist, PC
Suwanee, Georgia
Illinois Gastroenterology Group - Arlington Heights
Arlington Heights, Illinois
Northwestern University, Feinberg School of Medicine
Chicago, Illinois
University of Chicago Medical Center
Chicago, Illinois
Illinois Gastroenterology Group - Gurnee
Gurnee, Illinois
Indiana University Health University Hospital
Indianapolis, Indiana
University of Iowa Hospitals and Clinics
Iowa City, Iowa
University of Kansas Medical Center
Kansas City, Kansas
University of Louisville, School of Medicine
Louisville, Kentucky
Delta Research Partners, LLC
Monroe, Louisiana
Showing 40 of 513 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.